Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIO-RAD LABORATORIES, INC.

(BIO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
673.84(c) 668.42(c) 663.05(c) 675.41(c) 682.92(c) Last
76 376 121 768 130 199 80 069 67 916 Volume
-0.14% -0.80% -0.80% +1.86% +1.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 717 M - -
Net income 2021 423 M - -
Net cash position 2021 1 152 M - -
P/E ratio 2021 48,7x
Yield 2021 -
Sales 2022 2 753 M - -
Net income 2022 448 M - -
Net cash position 2022 1 581 M - -
P/E ratio 2022 46,0x
Yield 2022 -
Capitalization 20 287 M 20 287 M -
EV / Sales 2021 7,04x
EV / Sales 2022 6,80x
Nbr of Employees 8 000
Free-Float 70,8%
More Financials
Company
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and... 
More about the company
Ratings of Bio-Rad Laboratories, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about BIO-RAD LABORATORIES, INC.
07/16BIO RAD LABORATORIES : Rad to Report Second-Quarter 2021 Financial Results, Thur..
PU
07/14BIO RAD LABORATORIES : Rad to Report Second-Quarter 2021 Financial Results, Thur..
BU
07/06Seegene Announces Partnership with Bio-Rad to Develop Diagnostic Testing Prod..
CI
06/30BIO RAD LABORATORIES : Partners With Seegene to Develop, Commercialize Molecular..
MT
06/30BIO RAD LABORATORIES : Rad Announces Partnership with Seegene for Molecular Diag..
BU
06/30Bio-Rad Laboratories, Inc. Announces Partnership with Seegene for Molecular D..
CI
06/25BIO-RAD LABORATORIES, INC.(NYSE : BIO) added to Russell 1000 Dynamic Index
CI
06/21BIO RAD LABORATORIES : Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Q..
BU
06/21Bio-Rad Launches Its Prevalence Ddpcr Sars-Cov-2 Wastewater Quantification Ki..
CI
06/09BIO RAD LABORATORIES : Will The Real Inventor(s) Please Stand Up
AQ
05/3010X GENOMICS INC. V. BIO-RAD LABS., : PTAB Reiterates Patent Owner's Obligation..
AQ
05/24BIO RAD LABORATORIES : Rad Co-Ownership Defense Fails At The CAFC
AQ
05/20BIO RAD LABORATORIES : Rad to Participate at Jefferies Virtual Healthcare Confer..
BU
05/07BIO RAD LABORATORIES : Ideas Not Rising To The Level Of Protectable IP Do Not Tr..
AQ
04/30BIO RAD LABORATORIES : Management's Discussion and Analysis of Financial Conditi..
AQ
More news
News in other languages on BIO-RAD LABORATORIES, INC.
2020L'ombre d'un doute
2020EN DIRECT DES MARCHES : Peugeot, Orange, Verallia, Solocal, Valneva, easyJet,..
2020AKTIE IM FOKUS : Sartorius können Rekordhoch nicht verteidigen - Verluste
2019STOCK MARKET PARIS : Paris attend des clarifications
2019Bourse - sartorius stedim biotech gagne 1,9%, jpmorgan ayant entamé le suivi ..
More news
Analyst Recommendations on BIO-RAD LABORATORIES, INC.
More recommendations
Chart BIO-RAD LABORATORIES, INC.
Duration : Period :
Bio-Rad Laboratories, Inc. Technical Analysis Chart | BIO | US0905722072 | MarketScreener
Technical analysis trends BIO-RAD LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 682,92 $
Average target price 667,50 $
Spread / Average Target -2,26%
EPS Revisions
Managers and Directors
Norman D. Schwartz Chairman, President & Chief Executive Officer
Ilan Daskal Chief Financial Officer & Executive Vice President
Andrew J. Last Chief Operating Officer & Executive Vice President
Jeffrey L. Edwards Independent Director
Gregory K. Hinckley Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BIO-RAD LABORATORIES, INC.15.86%18 583
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667